Colorimetric determination of arylsulfatase A activity in plasma verified the deficit, suggesting late-infantile MLD in all three patients to be formally confirmed by genetic testing, as recommended by current guidelines [21]. This evidence concerns the gene ARSA and metachromatic leukodystrophy.